Role and effective therapeutic target of gut microbiota in NAFLD/NASH.

导出 LinkOut

翻译打印收藏纠错

作者： Qun,Liu ^[1] ; Shousheng,Liu ^[2] ; Lizhen,Chen ^[3] ; Zhenzhen,Zhao ^[4] ; Shuixian,Du ^[2] ; Quanjiang,Dong ^[5] ; Yongning,Xin ^[3] ; Shiying,Xuan ^[4]

作者单位： Medical College of Qingdao University, Qingdao, Shandong 266071, P.R. China. ^[1] Department of Gastroenterology, Qingdao Municipal Hospital, Qingdao, Shandong 266011, P.R. China. ^[2] Central Laboratories, Qingdao Municipal Hospital, Qingdao, Shandong 266071, P.R. China. ^[3] Digestive Disease Key Laboratory of Qingdao, Qingdao, Shandong 266071, P.R. China. ^[4] Department of Infectious Disease, Qingdao Municipal Hospital, Qingdao, Shandong 266011, P.R. China. ^[5]

关键词 anti-diabetic gut microbiota liver-gut axis non-alcoholic fatty liver disease

DOI 10.3892/etm.2019.7781

PMID 31410156

发布时间 2020-09-30

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交